2seventy bio, Inc. Common Stock
TSVT US9013841070
💰
Capitalization
Small-cap
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
🔗
Website
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 86% | -65% | -54% | -28% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
📊
Transactions
31
🙍
Insiders
6
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Baird William D Iii CEO |
4.95 USD |
5,092 Sold |
25,180 USD |
17/03/2025 | 17/03/2025 |
| Snow Jessica COO |
4.95 USD |
2,298 Sold |
11,364 USD |
17/03/2025 | 17/03/2025 |
| Eatwell Victoria CFO |
4.95 USD |
2,592 Sold |
12,817 USD |
17/03/2025 | 17/03/2025 |
| Snow Jessica O |
2.64 USD |
186 Sold |
491 USD |
03/01/2025 | 07/01/2025 |
| Snow Jessica O |
2.78 USD |
114 Sold |
317 USD |
03/01/2025 | 06/01/2025 |
| Leschly Nick O |
2.78 USD |
892 Sold |
2,478 USD |
03/01/2025 | 06/01/2025 |
| Snow Jessica O |
2.79 USD |
5,000 Sold |
13,972 USD |
03/01/2025 | 06/01/2025 |
| Baird William D Iii CEO |
2.78 USD |
763 Sold |
2,120 USD |
03/01/2025 | 06/01/2025 |
| Eatwell Victoria CFO |
2.78 USD |
97 Sold |
270 USD |
03/01/2025 | 06/01/2025 |
| Baird William D Iii CEO |
2.94 USD |
31,718 Sold |
93,121 USD |
03/01/2025 | 03/01/2025 |